Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease

NCT04912427 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Multiple Myeloma

Interventions

DRUG: Isatuximab
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Washington University School of Medicine

Collaborators

[object Object]